Davenport Downgrades VIVUS, Inc. (VVUS) to Neutral
Tweet Send to a FriendGet Alerts VVUS Hot Sheet
Price: $14.50 +7.25%
Rating Summary:
6 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
6 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade VVUS Now!
Davenport downgrades VIVUS, Inc. (Nasdaq: VVUS) from Buy to Neutral.
To see all the upgrades/downgrades on shares of VVUS, visit our Analyst Ratings page.
VIVUS, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutic products for underserved markets.
To see all the upgrades/downgrades on shares of VVUS, visit our Analyst Ratings page.
VIVUS, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutic products for underserved markets.
You May Also Be Interested In
- Vivus (VVUS) Sees Upside on Icahn Connection
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
- QVT Financial Purchase $20M of Convertible Debt Issued by VIVUS (VVUS)
Create E-mail Alert Related Categories
DowngradesRelated Entities
Davenport
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
